Sign In
Buy GENB
Latest Data & Signals Issued
Below are some of the latest signals issued for Generate Biomedicines, Inc.
General
| Signal Type | Signal Value | Data | |
|---|---|---|---|
| Score | -0.263 | 2 days ( -2.58 % | |
| Last Price | $14.72 | 2.58 % | |
Performance History
7 Days
$14.34
$14.72
2.65%
30 Days
$14.33
$14.72
2.76%
|
|||
6/15
Active Buy Signals
|
Specific Signals
| Signal Type | Signal Value | Importance | Data | |
|---|---|---|---|---|
| High / Low | Neutral | Very Low |
$14.24
- $14.88
Position: 74.98% from low / 25.02% from high · Momentum: 2.64% |
|
| Trend - 3 mos | 2.61 % | High | Width: 42.97 % | |
| Pred. range - 3 mos | $12.63 - $18.06 | Low | -14.20 % - 22.66 % | |
| Volume Direction | Sell | High | Volume: 527,468 · Direction: 0 | |
| Pivot Short | Buy | Very Low | Jul 29, 2026 - 9 days | |
| RSI Short Pivot Signal | Sell | Very Low | Aug 07, 2026 - 2 days | |
| Short MA 3 mos | Sell | Low | Aug 05, 2026 - 4 days | |
| Long MA 3 mos | Sell | Medium | Jul 09, 2026 - 23 days | |
| Short/Long MA 3 mos | Sell | Medium | Jul 16, 2026 - 18 days |
| Signal Type | Signal Value | Importance | Data | |
|---|---|---|---|---|
| Trend - 12 mos | 19.68 % | Very High | Width: 36.93 % | |
| Pred. range - 12 mos | N/A - N/A | High | ||
| Pivot Long | Sell | Low | Jul 02, 2026 - 27 days | |
| RSI Long Pivot Signal | Sell | Low | Aug 07, 2026 - 2 days | |
| Bollinger | Buy | Medium | Aug 10, 2026 - 1 day | |
| MACD | Buy | High | No Dates Stored For This Signal |
Signals Effectiveness
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
